HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

verlukast

LTD4 receptor antagonist
Also Known As:
(3-(3-(2-(7-chloro-2-quinolinyl)ethenyl)phenyl)((3-dimethylamino-3-oxopropyl)thio)methyl)thiopropanoic acid; L 660,711; L 660711; L-660711; MK 0571; MK 0679; MK 571; MK-0571; MK-0679; MK-571; MK-679; MK571 cpd; verlukast, (R-(E))-isomer
Networked: 50 relevant articles (4 outcomes, 10 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Kawai, Keiichi: 3 articles (11/2020 - 11/2018)
2. Kobayashi, Masato: 3 articles (11/2020 - 11/2018)
3. Mizutani, Asuka: 3 articles (11/2020 - 11/2018)
4. Nakanishi, Takeo: 3 articles (11/2020 - 11/2018)
5. Nishi, Kodai: 3 articles (11/2020 - 11/2018)
6. Nishii, Ryuichi: 3 articles (11/2020 - 11/2018)
7. Tamai, Ikumi: 3 articles (11/2020 - 11/2018)
8. Wang, J-J: 2 articles (05/2015 - 05/2014)
9. Yang, Y-C: 2 articles (05/2015 - 05/2014)
10. Abreu da Silveira, Keila: 1 article (10/2021)

Related Diseases

1. Asthma (Bronchial Asthma)
2. Acute Kidney Injury (Acute Renal Failure)
3. Ischemia
4. Hypersensitivity (Allergy)
5. Pneumonia (Pneumonitis)

Related Drugs and Biologics

1. Leukotrienes
2. Leukotriene D4
3. Lipoxygenase Inhibitors
4. Bleomycin (Blenoxane)
5. zileuton (Zyflo)
6. leukotriene D4 receptor (cysteinyl leukotriene receptor)
7. Antigens
8. Proteins (Proteins, Gene)
9. multidrug resistance-associated protein 1
10. Leukotriene Antagonists (Leukotriene Receptor Antagonists)

Related Therapies and Procedures

1. Aftercare (After-Treatment)
2. Catheters
3. Therapeutics
4. Injections
5. Controlled Hypotension